Madopar

Levodopa/Benserazide, the active ingredient in Madopar, is an antiparkinson agent presented as an oral tablet for oral use. It is used to manage motor symptoms in Parkinson's disease and related Parkinsonian syndromes. GNH USA supplies Madopar as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Madopar is an antiparkinson medication that targets dopaminergic pathways to improve motor function. - Parkinson's disease: improves bradykinesia, rigidity and tremor in patients with idiopathic Parkinson's disease. - Parkinsonian syndrome: alleviates motor deficits in secondary parkinsonism caused by other neurological conditions. - Levodopa‑responsive motor fluctuations: reduces off‑periods and enhances daily functional ability in patients experiencing fluctuating symptoms.

Adverse reactions may occur with Madopar use.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Orthostatic hypotension: dizziness upon standing. - Headache: transient cranial discomfort. - Insomnia: difficulty initiating sleep. - Dry mouth: reduced salivation. - Constipation: slowed gastrointestinal motility.

Serious or Rare Side Effects: - Dyskinesia: involuntary, erratic movements. - Hallucinations or psychosis: visual or auditory disturbances. - Severe hypotension: marked blood pressure drop. - Neuroleptic malignant syndrome: rare life‑threatening reaction. - Cardiac arrhythmias: irregular heart rhythm. - Allergic reactions: rash, swelling, or anaphylaxis.

Patients should be monitored for specific safety considerations when using Madopar. - Monitor blood pressure: watch for orthostatic hypotension, especially during dose initiation. - Assess hepatic function: adjust use in patients with liver impairment. - Review psychiatric history: increased risk of hallucinations or confusion. - Avoid abrupt discontinuation: may cause worsening of Parkinsonian symptoms. - Store at ambient temperature: keep in original container, protect from moisture and light.

Madopar may interact with several medicines, requiring careful management.

Major Interactions (Avoid): - Non‑selective MAO inhibitors: risk of hypertensive crisis. - Anticholinergic agents: may mask therapeutic effects. - Iron or calcium supplements: reduce levodopa absorption. - High‑protein meals: interfere with levodopa uptake.

Moderate Interactions (Monitor Closely): - Selective MAO‑B inhibitors: may increase dopaminergic activity. - Antihypertensive drugs: additive hypotensive effect. - SSRIs or SNRIs: potential for serotonin syndrome.